Tandem Diabetes Care (TNDM) Operating Expenses (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Operating Expenses for 14 consecutive years, with $158.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 10.75% year-over-year to $158.6 million; the trailing twelve-month figure through Jun 2026 stood at $629.1 million (down 13.31% YoY), and the FY2025 full-year result was $733.3 million, up 24.56% from the prior year.
• Operating Expenses rose to $158.6 million in Q2 2026 per TNDM's latest filing, from $154.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $239.3 million in Q1 2025 and bottomed at $106.4 million in Q1 2022.
• Historically, Operating Expenses has averaged $152.3 million across 5 years, with a median of $151.3 million in 2022.
• The sharpest annual moves came in 2023 and 2026: Operating Expenses jumped 97.99% in 2023, then slumped 35.55% in 2026.
• Over 5 years, Operating Expenses stood at $133.3 million in 2022, then declined by 3.71% to $128.4 million in 2023, then rose by 23.12% to $158.0 million in 2024, then climbed by 0.72% to $159.2 million in 2025, then declined by 0.37% to $158.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $158.6 million, $154.2 million, and $159.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.